XTL Biopharmaceuticals Market Cap

XTL Biopharmaceuticals has a market cap or net worth of 19.87 million as of March 9, 2026. Its market cap has decreased by -74.03% in one year.

Market Cap

19.87M

Enterprise Value

19.29M

Revenue

3.26M

Ranking

n/a

PE Ratio

n/a

Stock Price

2.20

Market Cap Chart

Since August 30, 2005, XTL Biopharmaceuticals's market cap has decreased from 805.44M to 19.87M, a decrease of -97.53%. That is a compound annual growth rate of -16.50%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	19.87M	-12.50%
Dec 31, 2025	22.71M	-72.15%
Dec 31, 2024	81.53M	327.50%
Dec 31, 2023	19.07M	-14.63%
Dec 29, 2022	22.34M	-52.02%
Dec 30, 2021	46.56M	-7.60%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 31, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Can-Fite BioPharma	19.70M
Purple Biotech	18.58M
Evogene	21.42M
BioLight Life Sciences	31.31M
BioLineRx	39.16M
Clal Biotechnology Industries	46.43M
Matricelf	146.87M
Geffen Residence & Renewal	277.04M

Market Cap Rankings